Cyclosporine A-nanoparticles enhance the therapeutic benefit of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model

International Journal of Nanomedicine

Volumn 9, Issue 1, 2013, Pages 17-26

  Yin, Qiaoxiang ^a   Pei, Zhiyong ^b   Wang, Heng ^a   Zhao, Yusheng ^b  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Adipose tissue derived stem cells; Cyclosporine A; Cyclosporine A nanoparticle emulsion; Myocardial infarction

Indexed keywords

CYCLOSPORIN A; MYOSIN HEAVY CHAIN; NANOPARTICLE; TROPONIN T;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL COUNT; CELL PROTECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DATA ANALYSIS; ENGRAFTMENT; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; SWINE; TREATMENT RESPONSE;

ADIPOSE TISSUE-DERIVED STEM CELLS; CYCLOSPORINE A; CYCLOSPORINE A NANOPARTICLE EMULSION; MYOCARDIAL INFARCTION;

ADIPOCYTES; ANIMALS; COMBINED MODALITY THERAPY; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; MALE; MYOCARDIAL INFARCTION; NANOCAPSULES; PARTICLE SIZE; STEM CELL TRANSPLANTATION; SWINE; TREATMENT OUTCOME;

EID: 84890324224     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S52005     Document Type: Article

References (23)

1. Shi CZ, Zhang XP, Lv ZW, etal. Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model. Int J Cardiol. 2012;154(1):2-8.
2. De Ugarte DA, Morizono K, Elbarbary A, etal. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101-109.
3. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93-98.
4. Perrelli MG, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species. World J Cardiol. 2011;3(6):186-200.
5. Piot C, Croisille P, Staat P, etal. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359(5): 473-481.
6. Tjia JF, Webber IR, Back DJ. Cyclosporin metabolism by the gastrointestinal mucosa. Br J Clin Pharmacol. 1991;31(3):344-346.
7. Zhang Y, Li X, Zhou Y, etal. Preparation and evaluation of poly(ethylene glycol)-poly(lactide) micelles as nanocarriers for oral delivery of cyclosporine a. Nanoscale Res Lett. 2010;5(6):917-925.
8. Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine. Chem Pharm Bull (Tokyo). 2010;58(5):650-655.
9. Yin QX, Pei ZY, Wang H, Zhao YS. [Pretreatment with cyclosporin A nanoparticles emulsion protects apoptosis of swine adipose tissue-derived stem cells]. Zhonghua Xin Xue Guan Bing Za Zhi. 2013;41(6): 501-506. Chinese.
10. Monaco E, de Lima AS, Bionaz M, etal. Morphological and transcriptomic comparison of adipose and bone marrow derived porcine stem cells. J Tissue Eng Regen Med. 2009;2:20-33.
11. Lim SY, Hausenloy DJ, Arjun S, etal. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J Cell Mol Med. 2011;15(11):2443-2451.
12. Malouitre S, Dube H, Selwood D, Crompton M. Mitochondrial targeting of cyclosporin A enables selective inhibition of cyclophilin-D and enhanced cytoprotection after glucose and oxygen deprivation. Biochem J. 2010;425(1):137-148.
13. Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur J Pharmacol. 2012;675(1-3):40-46.
14. Jameel MN, Zhang J. Stem cell therapy for ischemic heart disease. Antioxid Redox Signal. 2010;13(12):1879-1897.
15. Monaco E, Bionaz M, Rodriguez-Zas S, Hurley WL, Wheeler MB. Transcriptomics comparison between porcine adipose and bone marrow mesenchymal stem cells during in vitro osteogenic and adipogenic differentiation. PLoS One. 2012;7(3):e32481.
16. Madonna R, De Caterina R. Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown). 2010;11(2): 71-80.
17. Duckers MD. Treating heart attack with fat-derived stem cells may be safe in humans be safe in humans. In: American Heart Association Meeting Report; November 16, 2010; Chicago, IL. Abstract 12225.
18. Schoenhard JA, Hatzopoulos AK. Stem cell therapy: pieces of the puzzle. J Cardiovasc Transl Res. 2010;3(1):49-60.
19. Moreira Rde C, Haddad AF, Silva SA, etal. Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study. Arq Bras Cardiol. 2011;97(5):420-426.
20. Dube H, Selwood D, Malouitre S, Capano M, Simone MI, Crompton M. A mitochondrial-targeted cyclosporin A with high binding affinity for cyclophilin D yields improved cytoprotection of cardiomyocytes. Biochem J. 2012;441(3):901-907.
21. Mewton N, Croisille P, Gahide G, etal. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol. 2010;55(12):1200-1205.
22. Fujiwara M, Yan P, Otsuji TG, etal. Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One. 2011;6(2):e16734.
23. Yan P, Nagasawa A, Uosaki H, etal. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells. Biochem Biophys Res Commun. 2009;379(1):115-120.